← FDA DRUG APPROVALS

FDA ANDA · ANDA076392

MEFLOQUINE HYDROCHLORIDE

Sponsor: BARR

APPLICATION
ANDA076392
TYPE
ANDA
ORIGINAL APPROVAL
2003-12-29
LATEST ACTION
2016-10-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

MEFLOQUINE HYDROCHLORIDEPrescription
MEFLOQUINE HYDROCHLORIDE 250MG · TABLET · ORAL

Approval history

2016-10-11Labeling · Supplement 9 · standardAP
2013-07-26Labeling · Supplement 8 · standardLabelAP
2011-09-20Labeling · Supplement 5AP
2009-11-18Labeling · Supplement 4AP
2009-06-12Labeling · Supplement 3AP
2003-12-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →